| Inflammatory and coagulation biomarkers and mortality in patients with HIV infection LH Kuller, R Tracy, W Belloso, SD Wit, F Drummond, HC Lane, ... PLoS medicine 5 (10), e203, 2008 | 1944 | 2008 |
| A randomized trial of convalescent plasma in Covid-19 severe pneumonia VA Simonovich, LD Burgos Pratx, P Scibona, MV Beruto, MG Vallone, ... New England Journal of Medicine 384 (7), 619-629, 2021 | 1067 | 2021 |
| Inflammation, coagulation and cardiovascular disease in HIV-infected individuals DA Duprez, J Neuhaus, LH Kuller, R Tracy, W Belloso, S De Wit, ... Public Library of Science 7 (9), e44454, 2012 | 618 | 2012 |
| Interruption of antiretroviral therapy and risk of cardiovascular disease in persons with HIV-1 infection: exploratory analyses from the SMART trial AN Phillips, A Carr, J Neuhaus, F Visnegarwala, R Prineas, WJ Burman, ... Antiviral therapy 13 (2), 177-188, 2008 | 310 | 2008 |
| Changes in inflammatory and coagulation biomarkers: a randomized comparison of immediate versus deferred antiretroviral therapy in patients with HIV infection JV Baker, J Neuhaus, D Duprez, LH Kuller, R Tracy, WH Belloso, S De Wit, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 56 (1), 36-43, 2011 | 190 | 2011 |
| Risk for opportunistic disease and death after reinitiating continuous antiretroviral therapy in patients with HIV previously receiving episodic therapy: a randomized trial SMART Study Group* Annals of internal medicine 149 (5), 289-299, 2008 | 167 | 2008 |
| Historia de los antibióticos WH Belloso Rev. Hosp. Ital. B. Aires 29 (2), 102-11, 2009 | 103 | 2009 |
| Contribution of genetic background, traditional risk factors, and HIV-related factors to coronary artery disease events in HIV-positive persons M Rotger, TR Glass, T Junier, J Lundgren, JD Neaton, ES Poloni, ... Clinical infectious diseases 57 (1), 112-121, 2013 | 85 | 2013 |
| Efavirenz versus boosted atazanavir or zidovudine and abacavir in antiretroviral treatment-naive, HIV-infected subjects: week 48 data from the Altair study RL Puls, P Srasuebkul, K Petoumenos, C Boesecke, C Duncombe, ... Clinical infectious diseases 51 (7), 855-864, 2010 | 85 | 2010 |
| A Randomized, Controlled, Phase II Trial Comparing Escalating Doses of Subcutaneous Interleukin-2 plus Antiretrovirals versus Antiretrovirals Alone in Human Immunodeficiency … MH Losso, WH Belloso, S Emery, JA Benetucci, PE Cahn, MC Lasala, ... The Journal of infectious diseases 181 (5), 1614-1621, 2000 | 84 | 2000 |
| Nuevos indicadores clínicos: La calidad de vida relacionada con la salud E Consiglio, WH Belloso Medicina (Buenos Aires) 63 (2), 172-178, 2003 | 79 | 2003 |
| Influence of CYP3A5 polymorphism on tacrolimus maintenance doses and serum levels after renal transplantation: Age dependency and pharmacological … JR Ferraris, PF Argibay, L Costa, G Jimenez, PA Coccia, LFR Ghezzi, ... Pediatric transplantation 15 (5), 525-532, 2011 | 67 | 2011 |
| Analysis of serious non‐AIDS events among HIV‐infected adults at Latin American sites WH Belloso, LC Orellana, B Grinsztejn, JS Madero, A La Rosa, VG Veloso, ... HIV medicine 11 (9), 554-564, 2010 | 66 | 2010 |
| Determination of the underlying cause of death in three multicenter international HIV clinical trials AR Lifson, WH Belloso, C Carey, RT Davey, D Duprez, WM El-Sadr, ... HIV clinical trials 9 (3), 177-185, 2008 | 66 | 2008 |
| RBD-specific polyclonal F (ab) 2 fragments of equine antibodies in patients with moderate to severe COVID-19 disease: A randomized, multicenter, double-blind, placebo … G Lopardo, WH Belloso, E Nannini, M Colonna, S Sanguineti, ... EClinicalMedicine 34, 2021 | 58 | 2021 |
| Development of diagnostic criteria for serious non-AIDS events in HIV clinical trials AR Lifson, WH Belloso, RT Davey, D Duprez, JM Gatell, JF Hoy, EA Krum, ... HIV clinical trials 11 (4), 205-219, 2010 | 50 | 2010 |
| Bone mineral density in HIV participants randomized to raltegravir and lopinavir/ritonavir compared with standard second line therapy A Martin, C Moore, PWG Mallon, J Hoy, S Emery, W Belloso, ... Aids 27 (15), 2403-2411, 2013 | 49 | 2013 |
| AIDS in Latin America P Cahn, WH Belloso, J Murillo, G Prada-Trujillo Infectious Disease Clinics of North America 14 (1), 185-209, 2000 | 46 | 2000 |
| Artificial pancreas: clinical study in Latin America without premeal insulin boluses R Sánchez-Peña, P Colmegna, F Garelli, H De Battista, D García-Violini, ... Journal of diabetes science and technology 12 (5), 914-925, 2018 | 44 | 2018 |
| Water, electrolytes, and acid-base alterations in human immunodeficiency virus infected patients CG Musso, WH Belloso, RJ Glassock World journal of nephrology 5 (1), 33, 2016 | 37 | 2016 |
